|
Volumn 101, Issue 7, 2007, Pages 1059-1069
|
Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex
|
Author keywords
Chronic toxicity; Hematology and clinical chemistry; Hepatic lipid peroxidation and DNA fragmentation; Histopathology; Oxygen coordinated niacin bound chromium (III)
|
Indexed keywords
CHROMEMATE;
DNA FRAGMENT;
LIPID;
NIACIN BOUND CHROMIUM;
NICOTINIC ACID DERIVATIVE;
OXYGEN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BODY WEIGHT;
BRAIN WEIGHT;
CLINICAL CHEMISTRY;
COMPLEX FORMATION;
CONTROLLED STUDY;
DIET SUPPLEMENTATION;
DRUG EFFECT;
DRUG SAFETY;
DRUG SCREENING;
FEEDING BEHAVIOR;
FEMALE;
FLUID INTAKE;
HEMATOLOGY;
HISTOPATHOLOGY;
LIPID PEROXIDATION;
LIVER WEIGHT;
LONG TERM CARE;
MALE;
NONHUMAN;
PHYSICAL ACTIVITY;
RAT;
RISK ASSESSMENT;
SAFETY;
TREATMENT DURATION;
WEIGHT REDUCTION;
ADMINISTRATION, ORAL;
ANIMALS;
BODY WEIGHT;
BRAIN;
CHROMIUM COMPOUNDS;
DNA FRAGMENTATION;
EATING;
FEMALE;
HUMANS;
LIPID PEROXIDATION;
LIVER;
MALE;
NIACIN;
ORGAN SIZE;
OXYGEN;
RATS;
RATS, SPRAGUE-DAWLEY;
THERAPEUTIC EQUIVALENCY;
TIME FACTORS;
ANIMALIA;
RATTUS;
|
EID: 34250221472
PISSN: 01620134
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jinorgbio.2007.03.015 Document Type: Article |
Times cited : (24)
|
References (22)
|